Episode 211: semaglutide for AUD, preventing post-vax syncope, PCR panel for RTI, fluvoxamine for long-COVID

<p>Join primary care professors Mark Ebell, Kate Rowland, Gary Ferenchick and Henry Barry as they discuss 4 new studies: semaglutide for alcohol use disorder, a vibrating cool pack to prevent post vaccination syncope, PCR for 23 respiratory pathogens in primary care to reduce antibiotic use, and fluvoxamine for Long-COVID Fatigue.</p><p>Links</p><p>Semaglutide for AUD: <a href="https://pubmed.ncbi.nlm.nih.gov/42070571/"><u>https://pubmed.ncbi.nlm.nih.gov/42070571/</u></a></p><p>Vibrating cool pack for vaccine syncope: <a href="https://pubmed.ncbi.nlm.nih.gov/41692229/"><u>https://pubmed.ncbi.nlm.nih.gov/41692229/</u></a> </p><p>Point of care PCR for acute RTI: <a href="https://pubmed.ncbi.nlm.nih.gov/42149561/"><u>https://pubmed.ncbi.nlm.nih.gov/42149561/</u></a></p><p>Likelihood that pathogen is commensal vs pathogenic: <a href="https://pubmed.ncbi.nlm.nih.gov/39864052/ " target="_blank" rel="noopener noreferer">https://pubmed.ncbi.nlm.nih.gov/39864052/ </a></p><p>Fluvoxamine and long COVID: <a href="https://pubmed.ncbi.nlm.nih.gov/41911553/"><em>Ann Intern Med</em><u>. 2026;179(5):621-628</u></a>  <a href="https://pubmed.ncbi.nlm.nih.gov/41911553/"><u>https://pubmed.ncbi.nlm.nih.gov/41911553/</u></a> </p><p><br></p><p><br></p>